Skip to content

Source filing unavailable

Q2 2020 · —
Revenue—
Net Income-$2.04Mno prior Q2 2019 on file
EPS Diluted-$4.86no prior Q2 2019 on file
Operating Income-$2,035,000—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q2 2019 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Acumen Pharmaceuticals, Inc. · CIK 1576885 · Engraved from SEC EDGAR